New multi-determinant strategy for a group a streptococcal vaccine designed for the Australian Aboriginal population

Nature Medicine

Volumn 6, Issue 4, 2000, Pages 455-459

  Brandt, Evelyn R ^a   Sriprakash, K S ^c   Hobb, Rhonda I ^a   Hayman, Wendy A ^a   Zeng, Weiguang ^b   Batzloff, Michael R ^a   Jackson, David C ^b   Good, Michael F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; STREPTOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; HUMAN; IMMUNOGENICITY; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; VACCINATION;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; AUSTRALIA; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DRUG DESIGN; EPITOPES, B-LYMPHOCYTE; HUMANS; INFANT; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; OCEANIC ANCESTRY GROUP; PEPTIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VACCINES, SYNTHETIC;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS SP. 'GROUP A';

EID: 0034071425     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/74719     Document Type: Article

References (25)

1. Carapetis, J.R., Wolff, D.R. & Currie, B.J. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory. Med. J. Aust. 164, 146-149 (1996).
2. Beachey, E.H., Seyer, J.M., Dale, J.B., Simpson, W.A. & Kang, A.H. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature 292, 457-459 (1981).
3. Bessen, D. & Fischetti, V.A. Influence of intra nasal immunisation with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonisation by group A streptococci. Infect. Immun. 56, 2666-2672 (1988).
4. Pruksakorn, S. et al. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 344, 639-642 (1994).
5. Dale, J.B., Simmons, M., Xhiang, E.C. & Chiang, E.Y. Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine 14, 944-948 (1996).
6. Kotb, M., Courtney, H.S., Dale, J.B. & Beachey, E.H. Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M proteins. J. Immunol. 142, 966-979 (1989).
7. Pruksakorn, S. et al. Identification of T-cell autoepitopes that cross-react with the carboxyterminal segment of the M protein of Group A streptococci. Int. Immunol. 6, 1235-1244 (1994).
8. Relf, W.A. et al. Mapping a conserved conformational epitope from the M protein of group A streptococci. Peptide Res. 9, 12-20 (1996).
9. Hayman, W.A. et al. Mapping the minimal T and B cell epitope within a peptide vaccine candidate from the conserved region of the M protein of group A streptococci. Int. Immunol. 9, 1723-1733 (1997).
10. Brandt, E.R., Hayman, W.A., Currie, B., Pruksakorn, S. & Good, M.F. Human antibodies to the conserved region of the M protein: opsonisation of heterologous strains of group A streptococci. Vaccine 16, 1805-1812 (1997).
11. Relf, W.A., Martin, D.R. & Sriprakash, K.S Identification of sequence types among the m-nontypeable group A streptococci. J. Clin. Microbiol. 30, 3190-3194 (1992).
12. Gardiner, D. et al. Vir typing: A long-PCR typing method for group A streptococci. PCR Meth. Applic. 4, 288-293 (1995).
13. Quinn, R.W., Zwaag, R.W. & Lowry, P.N. Aquisition of group A streptococcal M protein antibodies. Ped. Infect. Dis. J. 4, 374-378 (1985).
14. Pruksakorn, S., Galbraith, A., Houghten, R.A. & Good, M.F. Conserved T and B cell epitopes on the M protein of group A streptococci: Induction of bactericidal antibodies. J. Immunol. 149, 2729-2735 (1992).
15. Robinson, J.H. & Kehoe, M.A. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol. Today 13, 362-367 (1992).
16. 2-terminal region of type 6 streptococcal M protein. J. Immunol. 136, 2287-2292 (1986).
17. O'Brien-Simpson, N.M., Ede, N.J., Brown, L.E., Swan, J. & Jackson, D.C. Polymerization of unprotected synthetic peptides: a view towards synthetic peptide vaccines. J. Am. Chem. Soc. 119, 1183-1188 (1997).
18. Jackson, D.C., O'Brien-Simpson, N., Ede, N.J. & Brown, L.E. Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine 15, 1697-1705 (1997).
19. Salvadori, L.G., Blake, M.S., McCarty, M., Tai, J.Y. & Zabriskie, J.B. Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J. Infect. Dis. 171, 593-600 (1995).
20. Brandt, E.R. et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 89, 331-337 (1986).
21. Ji, Y., Carlson. B., Kondagunta, A. & Cleary, P.P. Intranasal immunisation with C5a peptidase prevents nasopharyngeal colonisation of mice by group A streptococcus. Infect. Immun. 65, 2080-2087 (1997).
22. Kapur, V. et al. Vaccination with streptococcal cysteine protease protects mice against challenge with heterologous group A streptococci. Microb. Pathog. 16, 443-450 (1994).
23. Houghten, R.A. General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen- antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82, 5231-5235 (1985).
24. Coligan, J.E., Kruisbeek, A.M., Margulie, D.H., Shevach, E.M. & Strober, W. in Current Protocols in Immunology Vol. 2 (John Wiley, New York, 1992).
25. De Malmanche, S.A. & Martin, D.R. Protective immunity to the group A streptococcus may only be strain specific. Med. Microbiol. Immunol. 183, 299-306 (1996).